S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The gold catalyst we’ve waited for (Ad)
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
The gold catalyst we’ve waited for (Ad)
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The gold catalyst we’ve waited for (Ad)
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The gold catalyst we’ve waited for (Ad)
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
The gold catalyst we’ve waited for (Ad)
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The gold catalyst we’ve waited for (Ad)
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The gold catalyst we’ve waited for (Ad)
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
The gold catalyst we’ve waited for (Ad)
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The gold catalyst we’ve waited for (Ad)
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
The gold catalyst we’ve waited for (Ad)
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
The gold catalyst we’ve waited for (Ad)
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The gold catalyst we’ve waited for (Ad)
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
NASDAQ:RGEN

Repligen - RGEN Earnings Date, Estimates & Call Transcripts

$174.05
+1.73 (+1.00%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$173.55
▼
$177.54
50-Day Range
$166.27
▼
$198.10
52-Week Range
$137.21
▼
$262.26
Volume
477,111 shs
Average Volume
668,382 shs
Market Capitalization
$9.67 billion
P/E Ratio
53.55
Dividend Yield
N/A
Price Target
$216.86

Earnings Summary

Upcoming
Earnings Date
Apr. 26Estimated
Actual EPS
(Feb. 22)
$0.68 Beat By $0.10
Consensus EPS
(Feb. 22)
$0.58
Last Year's Q1 EPS
(2/17/2022)
$0.81
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

RGEN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RGEN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Repligen Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20234$0.56$0.68$0.60 
Q2 20234$0.58$0.63$0.60 
Q3 20234$0.66$0.72$0.70 
Q4 20234$0.71$0.83$0.76 
FY 202316$2.51$2.86$2.66 
Q1 20241$0.76$0.76$0.76 
Q2 20241$0.87$0.87$0.87 
Q3 20241$0.98$0.98$0.98 
Q4 20241$1.09$1.09$1.09 
FY 20244$3.70$3.70 $3.70

RGEN Earnings Date and Information

Repligen last issued its quarterly earnings data on February 22nd, 2023. The biotechnology company reported $0.68 EPS for the quarter, topping the consensus estimate of $0.58 by $0.10. The firm earned $186.80 million during the quarter, compared to analysts' expectations of $184.41 million. Its revenue for the quarter was up .2% compared to the same quarter last year. Repligen has generated $3.25 earnings per share over the last year ($3.25 diluted earnings per share) and currently has a price-to-earnings ratio of 53.6. Earnings for Repligen are expected to grow by 29.55% in the coming year, from $2.64 to $3.42 per share. Repligen has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 26th, 2023 based off prior year's report dates.

Repligen Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/26/2023
(Estimated)		        
2/22/2023Q4 2022$0.58$0.68+$0.10$0.51$184.41 million$186.80 million    
11/1/2022Q3 2022$0.68$0.77+$0.09$0.83$192.01 million$200.74 million
8/2/2022Q2 2022$0.72$0.91+$0.19$0.94$189.06 million$207.63 million    
4/27/2022Q1 2022$0.72$0.92+$0.20$1.03$185.48 million$206.40 million    
2/17/2022Q4 2021$0.65$0.81+$0.16$1.12$178.27 million$186.52 million    
10/28/20219/30/2021$0.64$0.78+$0.14$0.98$163.97 million$178.22 million    
7/26/20216/30/2021$0.52$0.79+$0.27$0.94$144.24 million$162.96 million    
5/4/20213/31/2021$0.42$0.68+$0.26$0.84$117.88 million$142.80 million  
2/23/202112/31/2020$0.31$0.52+$0.21$0.68$93.89 million$108.65 million  
11/5/20209/30/2020$0.28$0.40+$0.12$0.53$86.45 million$94.10 million  
7/30/20206/30/2020$0.28$0.42+$0.14$0.54$78.11 million$87.46 million  
5/6/20203/31/2020$0.22$0.32+$0.10$0.46$71.79 million$76.09 million  
2/20/2020Q4 2019$0.18$0.20+$0.02$0.33$68.37 million$69.47 million  
10/31/2019Q3 2019$0.19$0.26+$0.07$0.49$66.10 million$69.45 million  
8/1/2019Q2 2019$0.25$0.31+$0.06$0.45$65.47 million$70.70 million  
5/9/20193/31/2019$0.26$0.28+$0.02$0.39$55.09 million$60.63 million  
2/21/201912/31/2018$0.21$0.21$0.30$50.27 million$51.90 million  
11/1/20189/30/2018$0.18$0.20+$0.02$0.30$46.69 million$49.53 million
8/2/2018Q2 2018$0.18$0.16($0.02)$0.26$45.84 million$47.73 million
5/8/2018Q1 2018$0.15$0.17+$0.02$0.26$43.88 million$44.80 million
2/22/2018Q4 2017$0.12$0.20+$0.08$0.13$41.13 million$41.60 million
11/9/2017Q3 2017$0.11$0.15+$0.04$0.19$35.69 million$36.58 million
8/3/2017Q2 2017$0.1480$0.20+$0.0520$0.16$31.72 million$32.40 million  
5/4/20173/31/2017$0.13$0.15+$0.02$0.21$29.28 million$30.59 million  
2/22/2017Q4 2016$0.07$0.08+$0.01$0.01$24.05 million$25.60 million  
11/3/2016Q3 2016$0.08$0.08$0.13$24.39 million$24.70 million
8/4/2016Q2 2016$0.13$0.16+$0.03$0.21$24.75 million$29.20 million
5/5/2016Q1 2016$0.14$0.12($0.02)$0.19$22.54 million$25.10 million
2/25/2016Q4 2015$0.08$0.07($0.01)$0.13$19.84 million$21.40 million  
11/5/2015Q3 2015$0.08$0.08$0.08$20.50 million$19.80 million
8/6/2015Q2 2015$0.10$0.11+$0.01$0.11$20.05 million$21.50 million
5/7/2015Q1 2015$0.08$0.09+$0.01$0.09$18.20 million$20.82 million
3/13/2015Q4 2014$0.04($0.01)($0.05)($0.01)$14.70 million$15.40 million
11/6/2014Q3 2014$0.05$0.04($0.01)$0.04$15.60 million$15.30 million
8/11/2014Q2 2014$0.06$0.09+$0.03$0.09$14.90 million$15.60 million
5/8/2014Q1 2014$0.09$0.13+$0.04$0.13$15.14 million$16.33 million  
3/6/2014Q4 2013$0.10+$0.10$0.10$15.88 million$10.40 million  
11/7/2013Q3 2013$0.18+$0.18$0.18$16.27 million$18.80 million  
8/1/2013Q2 2013$0.14+$0.14$0.14$15.97 million$17.50 million  
5/2/2013Q1 2013$0.07+$0.07$0.07$12.82 million$16.46 million  
3/7/2013Q4 2012$0.07$0.31+$0.24$0.32
11/8/2012Q312$0.06+$0.06$8.63 million$15.10 million  
8/2/2012Q2 2012$0.01$0.05+$0.04$0.05
5/3/2012Q1 2012$0.04+$0.04$0.04
3/16/2012Q4 2011($0.04)($0.07)($0.03)($0.07)
10/27/2011Q3 2011($0.02)$0.02+$0.04$0.02
6/9/2011Q1 2011($0.03)($0.06)($0.03)($0.06)
2/9/2011Q4 2010($0.03)$0.01+$0.04$0.01
11/2/2010Q3 2010($0.04)$0.02+$0.06$0.02
8/5/2010Q2 2010$0.03+$0.03$0.03
6/9/2010Q1 2010($0.05)($0.05)($0.05)
2/4/2010Q4 2009($0.04)($0.01)+$0.03($0.01)
11/5/2009Q3 2009($0.04)($0.03)+$0.01($0.03)
8/6/2009Q2 2009($0.04)($0.04)($0.04)
6/11/2009Q1 2009($0.06)($0.09)($0.03)($0.09)
8/7/2008Q2 2008$0.16$0.26+$0.10$0.26
6/12/2008Q1 2008($0.10)($0.10)($0.10)
2/7/2008Q4 2007($0.05)($0.01)+$0.04($0.01)












Repligen Earnings - Frequently Asked Questions

When is Repligen's earnings date?

Repligen has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 26th, 2023 based off last year's report dates. Learn more on RGEN's earnings history.

Did Repligen beat their earnings estimates last quarter?

In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.68 earnings per share (EPS) to beat the analysts' consensus estimate of $0.58 by $0.10. Learn more on analysts' earnings estimate vs. RGEN's actual earnings.

How can I listen to Repligen's earnings conference call?

The conference call for Repligen's latest earnings report can be listened to online. Listen to Conference Call

How can I read Repligen's conference call transcript?

The conference call transcript for Repligen's latest earnings report can be read online. Read Transcript

How much revenue does Repligen generate each year?

Repligen (NASDAQ:RGEN) has a recorded annual revenue of $801.54 million.

How much profit does Repligen generate each year?

Repligen (NASDAQ:RGEN) has a recorded net income of $185.96 million. RGEN has generated $3.25 earnings per share over the last four quarters.

What is Repligen's price-to-earnings ratio?

Repligen (NASDAQ:RGEN) has a trailing price-to-earnings ratio of 53.55 and a forward price-to-earnings ratio of 65.93. The price/earnings-to-growth ratio is 2.69.

What is Repligen's EPS forecast for next year?

Repligen's earnings are expected to grow from $2.64 per share to $3.42 per share in the next year, which is a 29.55% increase.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:RGEN) was last updated on 3/22/2023 by MarketBeat.com Staff